paclitaxel has been researched along with Clear Cell Sarcoma of Soft Tissue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, M; Han, Q; Higuchi, T; Hoffman, RM; Hozumi, C; Kawaguchi, K; Murata, T; Nishino, H; Sugisawa, N; Tashiro, Y; Unno, M; Yamamoto, J | 1 |
1 other study(ies) available for paclitaxel and Clear Cell Sarcoma of Soft Tissue
| Article | Year |
|---|---|
Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon-Sulfur Lyases; Carcinoma; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Heterografts; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Sarcoma, Clear Cell; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |